Riskpilot← Back to searchSign inGet full accessPlastikkirurgi Skåne AB
ABActiveOrg 5565249918Hässleholmsvägen 1Medical specialists activities · NACE 8622Est. 19955-9 employees
Revenue 2025
SEK 7,3M
+11% vs 2024
EBITDA margin
32.5%
+22% vs 2024
Equity ratio
71.8%
Financial strength
Net profit 2025
SEK 1,6M
+47% vs 2024
| Revenue | SEK 7,3M | +11% |
| EBITDA | SEK 2,4M | +22% |
| Net profit | SEK 1,6M | +47% |
| Total assets | SEK 2,5M | -18% |
| Equity | SEK 1,8M | +38% |
| Employees | — | — |
Legal name
Plastikkirurgi Skåne AB
Org number
5565249918
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 juli 1995
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva plastikkirurgi ävensom idka därmed förenlig verksamhet.
Address
Hässleholmsvägen 1
Email
tor.svensjo@plastikkirurgiskane.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 094 | 6 747 | 5 306 | 6 582 | 7 283 |
| Staff expenses | — | — | — | — | −1 525 |
| EBITDA | 966 | 1 039 | 1 822 | 1 948 | 2 368 |
| Depreciation & amort. | −82 | −72 | −72 | −172 | −191 |
| EBIT | 884 | 967 | 1 750 | 1 776 | 2 177 |
| Net financials | −17 | −13 | −8 | −19 | −9 |
| Profit before tax | 866 | 953 | 1 742 | 1 376 | 2 004 |
| Tax | −185 | −196 | −361 | −296 | −415 |
| Net profit | 681 | 757 | 1 381 | 1 080 | 1 589 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 369 | 1 206 | 1 943 | 3 006 | 2 465 |
| Equity | 1 855 | 877 | 1 501 | 1 282 | 1 771 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 514 | 329 | 442 | 1 568 | 374 |
| Total debt | 514 | 329 | 442 | 1 568 | 374 |
EBITDA margin
32.5%
This company
15.8%
Market median
+106% vs market
20212025
Equity ratio
71.8%
This company
38.2%
Market median
+88% vs market
20212025
Return on equity
89.7%
This company
18.4%
Market median
+388% vs market
20212025
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20212025
Asset turnover
2.96×
This company
1.12×
Market median
+164% vs market
20212025
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TS Chief Executive Officer | Chief Executive Officer | 2022 |
PM | Audit | 2022 |
| Former (1) | ||
HT Audit | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Plastikkirurgi Skåne AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Tobias Edfors | Audit | 0 companies |
| Tor Svensjö | Chief Executive Officer | 0 companies |
| Patric Mathias Andersson | Audit | 0 companies |
| Jimmie Andreas Nilsson | Board of Directors | 0 companies |
| Marja Katriina Svensjö | Deputy Board Member | 0 companies |